Ongoing monitoring remains a cornerstone of survivorship care for patients with cancer, helping detect recurrence early and ...
Treatment with relacorilant plus Abraxane (nab-paclitaxel) may offer a broader option for patients with platinum-resistant ...
Relacorilant plus Abraxane showed benefit without biomarker testing, potentially expanding treatment access for patients with platinum-resistant ovarian cancer.
A major update appears in the Boxed Warning, the most prominent safety warning required by the FDA. The warning now ...
Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of medicine ...
The investigational oral therapy KTX-1001, also known as gintemetostat, is catching interest as a potential treatment for a subgroup of patients with multiple myeloma, as an expert explained in a ...
Sabari recommends regular activity, such as walking 30 minutes a day several times a week, to help maintain lung strength.
Nocturnal symptoms and musculoskeletal pain are filtered through relapse fear, driving repetitive interpretation of ...
Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...
The DURIPANC study evaluates Ampligen, an immune system modulator, in combination with Imfinzi, a PD-L1 immune checkpoint ...
Caring for someone with advanced NSCLC is challenging, and support is available for both caregivers and patients. As a caregiver, it is just as important to take time for self-care as it is to tend to ...
Dietitians share a fiber- and protein-rich pastina bean soup to help patients with colorectal cancer stay nourished and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results